PRIORI, SILVIA GIULIANA
 Distribuzione geografica
Continente #
NA - Nord America 12.236
EU - Europa 8.740
AS - Asia 6.641
AF - Africa 63
SA - Sud America 53
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 15
Totale 27.768
Nazione #
US - Stati Uniti d'America 12.162
CN - Cina 5.861
IE - Irlanda 2.596
UA - Ucraina 1.666
IT - Italia 1.020
DE - Germania 914
FI - Finlandia 880
SE - Svezia 741
SG - Singapore 551
GB - Regno Unito 453
FR - Francia 245
CA - Canada 69
RU - Federazione Russa 64
JP - Giappone 59
NL - Olanda 41
MU - Mauritius 40
BR - Brasile 39
IN - India 37
IR - Iran 26
BE - Belgio 21
ES - Italia 18
AU - Australia 17
HK - Hong Kong 15
PK - Pakistan 14
PT - Portogallo 14
EU - Europa 13
ID - Indonesia 13
PL - Polonia 12
CH - Svizzera 11
AT - Austria 10
SK - Slovacchia (Repubblica Slovacca) 9
EG - Egitto 8
IL - Israele 8
KR - Corea 7
CZ - Repubblica Ceca 6
GR - Grecia 6
AR - Argentina 5
CL - Cile 5
IQ - Iraq 5
MY - Malesia 5
PH - Filippine 5
TR - Turchia 5
ZA - Sudafrica 5
BD - Bangladesh 4
TW - Taiwan 4
VN - Vietnam 4
AE - Emirati Arabi Uniti 3
MT - Malta 3
MX - Messico 3
NZ - Nuova Zelanda 3
UZ - Uzbekistan 3
AM - Armenia 2
CO - Colombia 2
DK - Danimarca 2
DZ - Algeria 2
ET - Etiopia 2
LV - Lettonia 2
NP - Nepal 2
SO - Somalia 2
TN - Tunisia 2
XK - ???statistics.table.value.countryCode.XK??? 2
BY - Bielorussia 1
CY - Cipro 1
GE - Georgia 1
HU - Ungheria 1
JM - Giamaica 1
JO - Giordania 1
KE - Kenya 1
KG - Kirghizistan 1
KH - Cambogia 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
LT - Lituania 1
LU - Lussemburgo 1
MA - Marocco 1
NO - Norvegia 1
PA - Panama 1
PE - Perù 1
SI - Slovenia 1
VE - Venezuela 1
Totale 27.768
Città #
Dublin 2.593
Chandler 2.494
Jacksonville 2.150
Nanjing 1.740
Boardman 930
Ashburn 832
Nanchang 741
Princeton 651
Lawrence 586
Wilmington 540
Hebei 530
Changsha 481
Shenyang 453
Singapore 376
Jiaxing 375
Medford 375
Beijing 328
Tianjin 302
Helsinki 299
San Genesio Ed Uniti 257
Hangzhou 238
Woodbridge 197
Shanghai 183
Milan 179
Ann Arbor 125
Verona 111
Norwalk 107
Falls Church 93
New York 83
Seattle 72
Des Moines 55
Los Angeles 51
Toronto 50
Fairfield 49
Houston 47
Tokyo 45
Kunming 43
Washington 36
Rome 35
Jinan 32
Zhengzhou 32
Chicago 29
Ningbo 29
Tappahannock 29
Dearborn 28
Pavia 26
Guangzhou 23
Taizhou 22
Changchun 19
Brussels 18
London 17
Lanzhou 15
Missoula 15
Munich 14
Pune 14
Falkenstein 12
Mykolayiv 12
Orange 12
Palermo 12
Auburn Hills 11
Borås 11
Turin 11
Melito di Napoli 8
Piscataway 8
Saint Petersburg 8
San Francisco 8
Bari 7
Dallas 7
Madrid 7
Peshawar 7
Semarang 7
Zanjan 7
Fuzhou 6
Melbourne 6
Novokuznetsk 6
Phoenix 6
Redwood City 6
Rzeszów 6
Santa Clara 6
Tehran 6
Aduard 5
Brno 5
Fort Worth 5
Genoa 5
Hefei 5
Hyderabad 5
Kobe 5
Monza 5
Nottingham 5
Novara 5
Somma Lombardo 5
São Paulo 5
Tavira 5
Yekaterinburg 5
Zola Predosa 5
Alghero 4
Bastia umbra 4
Berlin 4
Brisbane 4
Cambridge 4
Totale 19.492
Nome #
Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology; ESC Committee for Practice Guidelines (CPG). Guidelines on the management of stable angina pectoris: executive summary: the Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology 182
Calcio antagonisti e aritmie da riperfusione miocardica 161
Tachicardia Ventricolare Polimorfa Catecolaminergica 134
From decision to shared-decision: Introducing patients' preferences into clinical decision analysis. 122
American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents; European Society of Cardiology Committee for Practice Guidelines. American college of cardiology/european society of cardiology clinical expert consensus documen on hypertrophic cardiomyopathy. A report of the american college of cardiology foundation task force on clinical expert consensus documents and the european society of cardiology committee for practice guidelines 108
Arrhythmogenic mechanisms in a mouse model of Catecholaminergic Polymorphic Ventricular Tachycardia. 108
A method of gene transfer for the treatment of recessive CPVT 104
La Sindrome di Brugada: aspetti clinici, criteri diagnostici, stratificazione prognostica. 89
Aspetti elettrofisiologici della modulazione dei canali del potassio ATP-dipendenti 87
Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol: Consensus Statement of the Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology 81
Genetic testing in the long QT syndrome: development and validation of an efficient approach to genotyping in clinical practice 81
Task Force. Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology. 80
La Sindrome di Brugada 79
Risk stratification in the Long-QT Syndrome 78
Task Force on Syncope, European Society of Cardiology.Guidelines on management (diagnosis and treatment) of syncope-update 2004. Executive Summary. 78
Computer simulation of wild-type and mutant human cardiac Na+ current 78
Molecular strategies for the electrophysiologist 77
2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/ American Heart Association Task Force on practice guidelines. American College of Cardiology Foundation/American Heart Association Task Force. 77
Gene-specific therapy for inherited arrhythmogenic diseases 76
Images in cardiovascular medicine. Endocardial implantation of a cardioverter-defibrillator in a 13-month-old child affected by long-QT syndrome and syndactyly. 75
European Society of Cardiology. Expert consensus document on the use of antiplatelet agents. The task force on the use of antiplatelet agents in patients with atherosclerotic cardiovascular disease of the European society of cardiology. 75
Spotlight on sudden cardiac death 75
Linee Guida. Task Force sulla Morte Cardiaca Improvvisa, Società Europea di Cardiologia. Riassunto delle raccomandazioni 75
Arrhythmogenic Right Ventricular Cardiomyopathy: Clinical Course and Predictors of Arrhythmic Risk 75
Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease 74
Abnormal Calcium Signalling and Sudden Cardiac Death Associated With Mutation of Calsequestrin. 73
A common polymorphism associated with antibiotic-induced cardiac arrhythmia 72
A cardiac arrhythmia syndrome caused by loss of ankyrin-B function 72
FKBP12.6 deficiency and defective calcium release channel (ryanodine receptor) function linked to exercise-induced sudden cardiac death. 71
Cardiac Sodium Channel Diseases 70
Long QT syndrome and catecholaminergic VT 70
Task Force on Clinical Expert Consensus Documents. American College of Cardiology; Committee for Practice Guidelines. European Society of Cardiology. American college of cardiology/european society of cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the american college of cardiology foundation task force on clinical expert consensus documents and the european society of cardiology committee for practice guidelines 69
Catecholaminergic Polymorphic Ventricular Tachycardia. 69
ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias-executive summary. a report of the American college of cardiology/American heart association task force on practice guidelines and the European society of cardiology committee for practice guidelines (writing committee to develop guidelines for the management of patients with supraventricular arrhythmias) Developed in Collaboration with NASPE-Heart Rhythm Society 68
Universal definition of the myocardial infarction 68
Inherited arrhythmogenic diseases 68
Beyond Cohort Selection: An Analytics-Enabled i2b2 68
A newly charactarized SCN5A mutation underlying Brugada Syndrome unmasked by Hyperthermia 68
Loss of function associated with novel mutations of the SCN5A gene in patients with Brugada syndrome 67
Cost-effectiveness of Neonatal ECG as a Screening for Long QT-syndrome: A Decision Analysis Approach. 67
Clinical and Molecular Characterization of Patients with Catecholominergic Polymorphic Ventricular Tachycardia. 67
Inherited arrhythmia: present and future perspectives for genetic therapy 67
Adrenergic Arrhythmogenesis and The Long QT syndrome 67
Idiopathic Ventricular Fibrillation. 67
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC 67
Universal definition of myocardial infarction. 67
Policy statement: ESC-ERC recommendations for the use of automated external defibrillators (AEDs) in Europe. 66
Guidelines On Diabetes, Pre-Diabetes, And Cardiovascular Diseases: Executive Summary.The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). 66
Acute oral drug testing in the evaluation of a new antiarrhythmic agent: Penticainide (CM 7857) 66
Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death--executive summary 66
Sympathetic activation, ventricular repolarization and Ikr blockade: implications for the antifibrillatory efficacy of potassium channel blocking agents 66
Proposed Diagnostic Criteria for the Brugada Syndrome. 65
Gene-specific therapy with mexiletine reduces arrhythmic events in patients with long QT syndrome type 3 65
Allele-Specific Silencing of Mutant mRNA Rescues Ultrastructural and Arrhythmic Phenotype in Mice Carriers of the R4496C Mutation in the Ryanodine Receptor Gene (RYR2). 65
Hydroquinidine Prevents Life-Threatening Arrhythmic Events in Patients With Short QT Syndrome 65
Yield of Genetic Screening in Inherited Cardiac Channelopathies. 64
Task Force Members; ESC Committee for Practice Guidelines (CPG); Document Reviewers. Guidelines on prevention, diagnosis and treatment of infective endocarditis executive summary; the task force on infective endocarditis of the European society of cardiology 63
Gender-specific prescription for cardiovascular diseases? 63
Molecular underpinning of ''good luck'' 63
Risk of aborted cardiac arrest or sudden cardiac death during adolescence in the long-QT syndrome. 63
ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society 63
Ryanodine receptor and calsequestrin in arrhythmogenesis: What we have learnt from genetic diseases and transgenic mice 63
SUDDEN CARDIAC DEATH 63
“Cardiac Risk Stratification by NOS1AP Genotyping” 63
The usual suspects in sudden cardiac death of the young: a focus on inherited arrhythmogenic diseases 63
Drug-induced torsades de pointes and implications for drug development. 63
Increased Ca2+ Sensitivity of the Ryanodine Receptor Mutant RyR2R4496C Underlies Catecholaminergic Polymorphic Ventricular Tachycardia. 63
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC 63
Clinical presentation and outcome of Brugada syndrome diagnosed with the new 2013 criteria 63
[2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac Death. The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology] 63
Genetic causes of sudden cardiac death in the young. 63
Interplay Between Genetic Substrate, QTc Duration, and Arrhythmia Risk in Patients With Long QT Syndrome 63
Clinical profile and genetic basis of Brugada syndrome in the Chinese population. 62
From genes to cell therapy: molecular medicine meets clinical EP 62
Epinephrine unmasks latent mutation carriers with LQT1 form of congenital long-QT syndrome. 62
Timothy Syndrome 62
R Engine Cell: integrating R into the i2b2 software infrastructure. 62
2010 Focused Update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC Guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association 62
Protective effect of vagal stimulation on reperfusion arrhythmias in cats. 62
2010 focused update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC Guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association 62
Gene therapy to treat cardiac arrhythmias 62
A Molecular Link between the Sudden Infant Death Syndrome and the Long-QT Syndrome. 62
Evaluation of BLS-D training in lay people. 61
Diagnosis and treatment of catecholaminergic polymorphic ventricular tachycardia. 61
Update of the guidelines on sudden cardiac death of the European Society of Cardiology 61
Progress in the evaluation of a new class I antiarrhythmic agent: Penticainide 61
Gene specific therapy for cardiac disease: the case of long QT Sydnrome 61
ST-Segment Elevation in the Setting of a Febrile Illness. 61
CaMKII inhibition rectifies arrhythmic phenotype in a patient-specific model of catecholaminergic polymorphic ventricular tachycardia. 61
Information extraction from Italian medical reports: An ontology-driven approach 61
La sindrome di Brugada: epidemiologia, stratificazione del rischio e management clinico. 61
Catecholaminergic Polymorphic Ventricular Tachycardia, Recurrent Syncope, and Implantable Loop Recorder 60
ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society 60
Molecular and electrophysiological bases of catecholaminergic polymorphic ventricular tachycardia. 60
Lack of correlation between occlusion and reperfusion arrhythmias in the cat. 60
New insights into the long-QT syndrome 60
Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12,440 patients of the ESC Heart Failure Long-Term Registry 60
Identificazione delle mutazioni intrageniche 60
Guidelines in cardiac pacing and resynchronization therapy. 60
Abnormal Interactions of Calsequestrin With the Ryanodine Receptor Calcium Release Channel Complex Linked to Exercise-Induced Sudden Cardiac Death 60
Totale 7.142
Categoria #
all - tutte 127.337
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 127.337


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.086 0 0 0 0 0 0 22 389 26 440 202 7
2020/20213.187 357 304 102 307 4 415 18 489 183 475 420 113
2021/20222.393 18 6 64 22 53 124 61 138 183 113 372 1.239
2022/20237.411 879 426 86 632 730 835 7 379 3.047 34 229 127
2023/20242.867 308 512 113 276 291 700 128 156 17 84 90 192
2024/20251.864 166 703 206 263 184 284 58 0 0 0 0 0
Totale 28.165